Pathogenesis of ANCA-associated Vasculitis

Rheumatic Disease Clinics of North America

Volumn 36, Issue 3, 2010, Pages 463-477

  Flint, Julia ^a,b   Morgan, Matthew D ^b   Savage, Caroline O S ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Antineutrophil cytoplasm antibody; Endothelium; Microscopic polyangiitis; Neutrophil; T cell; Vasculitis; Wegener's granulomatosis

Indexed keywords

AUTOANTIBODY; CELL ADHESION MOLECULE; ENDOTHELIAL CELL ANTIBODY; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANCA ASSOCIATED VASCULITIS; APOPTOSIS; B LYMPHOCYTE; ENDOTHELIUM; EXPERIMENTAL MOUSE; HUMAN; IMMUNOPATHOGENESIS; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; B-LYMPHOCYTES; CELL ADHESION; ENDOTHELIAL CELLS; HUMANS; MOLECULAR MIMICRY; NEUTROPHIL ACTIVATION; NEUTROPHILS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 77955237677     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2010.05.006     Document Type: Review

References (103)

1. Jennette J., Falk R., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
2. Falk R., Terrell R., Charles L., et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990, 87:4115-4119.
3. Harper L., Savage C. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 2000, 190:349-359.
4. Cockwell P., Brooks C., Adu D., et al. Interleukin-8: a pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int 1999, 55:1125-1127.
5. Kettritz R., Jennette J., Falk R. Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 1997, 8:386-394.
6. Hewins P., Morgan M., Holden N., et al. IL-18 is up-regulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int 2006, 69:605-615.
7. Mulder A.H., Heeringa P., Brouwer E., et al. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol 1994, 98:270-278.
8. Kocher M., Edberg J.C., Fleit H.B., et al. Antineutrophil cytoplasmic antibodies preferentially engage Fc gammaRIIIb on human neutrophils. J Immunol 1998, 161:6909-6914.
9. Williams J.M., Savage C.O. Characterization of the regulation and functional consequences of p21ras activation in neutrophils by antineutrophil cytoplasm antibodies. J Am Soc Nephrol 2005, 16:90-96.
10. Hewins P., Williams J.M., Wakelam M.J., et al. Activation of Syk in neutrophils by antineutrophil cytoplasm antibodies occurs via Fcgamma receptors and CD18. J Am Soc Nephrol 2004, 15:796-808.
11. Ben-Smith A., Dove S.K., Martin A., et al. Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fc{gamma} receptor ligation. Blood 2001, 98:1448-1455.
12. Kettritz R., Choi M., Butt W., et al. Phosphatidylinositol 3-kinase controls antineutrophil cytoplasmic antibodies-induced respiratory burst in human neutrophils. J Am Soc Nephrol 2002, 13:1740-1749.
13. Katzav A., Kloog Y., Korczyn A.D., et al. Treatment of MRL/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS). Clin Exp Immunol 2001, 126:570-577.
14. Yang J.J., Preston G.A., Alcorta D.A., et al. Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA). Kidney Int 2002, 62:1638-1649.
15. Donald K.J., Edwards R.L., McEvoy J.D. An ultrastructural study of the pathogenesis of tissue injury in limited Wegener's granulomatosis. Pathology 1976, 8:161-169.
16. Ewert B.H., Becker M.E., Jennette J.C., et al. Antimyeloperoxidase antibodies induce neutrophil adherence to cultured human endothelial cells. Ren Fail 1995, 17:125-133.
17. Keogan M.T., Rifkin I., Ronda N., et al. Anti-neutrophil cytoplasm antibodies (ANCA) increase neutrophil adhesion to cultured human endothelium. Adv Exp Med Biol 1993, 336:115-119.
18. Mayet W.J., Meyer zum Buschenfelde K.H. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 1993, 94:440-446.
19. Johnson P.A., Alexander H.D., McMillan S.A., et al. Up-regulation of the granulocyte adhesion molecule Mac-1 by autoantibodies in autoimmune vasculitis. Clin Exp Immunol 1997, 107:513-519.
20. Calderwood J.W., Williams J.M., Morgan M.D., et al. ANCA induces {beta}2 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium. J Leukoc Biol 2005, 77:33-43.
21. Radford D.J., Luu N.T., Hewins P., et al. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum 2001, 44:2851-2861.
22. Brachemi S., Mambole A., Fakhouri F., et al. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies. J Am Soc Nephrol 2007, 18:2330-2339.
23. Tse W., Nash G., Hewins P., et al. ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation. Kidney Int 2005, 67:130-139.
24. Ewert B.H., Jennette J.C., Falk R.J. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992, 41:375-383.
25. Savage C.O., Pottinger B.E., Gaskin G., et al. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992, 141:335-342.
26. Lu X., Garfield A., Rainger G.E., et al. Mediation of endothelial cell damage by serine proteases, but not superoxide, released from antineutrophil cytoplasmic antibody-stimulated neutrophils. Arthritis Rheum 2006, 54:1619-1628.
27. Yang J.J., Preston G.A., Pendergraft W.F., et al. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol 2001, 158:581-592.
28. Kumpers P., Hellpap J., David S., et al. Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement. Nephrol Dial Transplant 2009, 24:1845-1850.
29. Erdbruegger U., Grossheim M., Hertel B., et al. Diagnostic role of endothelial microparticles in vasculitis. Rheumatology (Oxford) 2008, 47:1820-1825.
30. de Groot K., Goldberg C., Bahlmann F.H., et al. Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2007, 56:3847-3853.
31. Zavada J., Kideryova L., Pytlik R., et al. Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford) 2009, 48:1197-1201.
32. Zavada J., Kideryova L., Pytlik R., et al. Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis. Kidney Blood Press Res 2008, 31:247-254.
33. Xiao H., Heeringa P., Hu P., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110:955-963.
34. Xiao H., Heeringa P., Liu Z., et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 2005, 167:39-45.
35. Nolan S.L., Kalia N., Nash G.B., et al. Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo. J Am Soc Nephrol 2008, 19:973-984.
36. Kuligowski M.P., Kwan R.Y., Lo C., et al. Antimyeloperoxidase antibodies rapidly induce alpha-4-integrin-dependent glomerular neutrophil adhesion. Blood 2009, 113:6485-6494.
37. Haas M., Eustace J.A. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 2004, 65:2145-2152.
38. Schreiber A., Xiao H., Jennette J.C., et al. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 2009, 20:289-298.
39. Xiao H., Schreiber A., Heeringa P., et al. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007, 170:52-64.
40. Xing G.Q., Chen M., Liu G., et al. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol 2009, 29:282-291.
41. Chen M., Xing G.Q., Yu F., et al. Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant 2009, 24:1247-1252.
42. Little M.A., Smyth L., Salama A.D., et al. Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am J Pathol 2009, 174:1212-1220.
43. Little M.A., Smyth C.L., Yadav R., et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 2005, 106:2050-2058.
44. Schlieben D.J., Korbet S.M., Kimura R.E., et al. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 2005, 45:758-761.
45. Harper L., Ren Y., Savill J., et al. Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages. Am J Pathol 2000, 157:211-220.
46. Harper L., Cockwell P., Adu D., et al. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int 2001, 59:1729-1738.
47. Gilligan H.M., Bredy B., Brady H.R., et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996, 184:2231-2241.
48. Schreiber A., Busjahn A., Luft F.C., et al. Membrane expression of proteinase 3 Is genetically determined. J Am Soc Nephrol 2003, 14:68-75.
49. von Vietinghoff S., Busjahn A., Schonemann C., et al. Major histocompatibility complex HLA region largely explains the genetic variance exercised on neutrophil membrane proteinase 3 expression. J Am Soc Nephrol 2006, 17:3185-3191.
50. Witko-Sarsat V., Lesavre P., Lopez S., et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 1999, 10:1224-1233.
51. Rarok A.A., Stegeman C.A., Limburg P.C., et al. Neutrophil membrane expression of proteinase 3 (PR3) Is related to relapse in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 2002, 13:2232-2238.
52. Henshaw T.J., Malone C.C., Gabay J.E., et al. Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum 1994, 37:104-112.
53. Ohlsson S., Wieslander J., Segelmark M. Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin Exp Immunol 2003, 131:528-535.
54. Taekema-Roelvink M.E., Van Kooten C., Heemskerk E., et al. Proteinase 3 interacts with a 111-kD membrane molecule of human umbilical vein endothelial cells. J Am Soc Nephrol 2000, 11:640-648.
55. Taekema-Roelvink M.E., Kooten C., Kooij S.V., et al. Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. J Am Soc Nephrol 2001, 12:932-940.
56. Bank U., Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol 2001, 69:197-206.
57. Novick D., Rubinstein M., Azam T., et al. Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci U S A 2006, 103:3316-3321.
58. Guilpain P., Servettaz A., Goulvestre C., et al. Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis. Arthritis Rheum 2007, 56:2455-2463.
59. Dolman K.M., van de Wiel B.A., Kam C.M., et al. Proteinase 3: substrate specificity and possible pathogenetic effect of Wegener's granulomatosis autoantibodies (c-ANCA) by dysregulation of the enzyme. Adv Exp Med Biol 1993, 336:55-60.
60. Griffith M.E., Coulthart A., Pemberton S., et al. Anti-neutrophil cytoplasmic antibodies (ANCA) from patients with systemic vasculitis recognize restricted epitopes of proteinase 3 involving the catalytic site. Clin Exp Immunol 2001, 123:170-177.
61. Daouk G.H., Palsson R., Arnaout M.A. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kidney Int 1995, 47:1528-1536.
62. Savige J.A., Chang L., Cook L., et al. Alpha 1-antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 1995, 100:194-197.
63. Segelmark M., Elzouki A.N., Wieslander J., et al. The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 1995, 48:844-850.
64. Kain R., Exner M., Brandes R., et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008, 14:1088-1096.
65. Damianovich M., Gilburd B., George J., et al. Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol 1996, 156:4946-4951.
66. Chan T.M., Frampton G., Jayne D.R., et al. Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasm antibodies. Am J Kidney Dis 1993, 22:387-392.
67. Holmen C., Christensson M., Pettersson E., et al. Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies. Kidney Int 2004, 66:1049-1060.
68. Del Papa N., Conforti G., Gambini D., et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1994, 70:211-216.
69. Matsumoto T., Kaneko T., Seto M., et al. The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis. Clin Appl Thromb Hemost 2008, 14:186-192.
70. Chow F.Y., Hooke D., Kerr P.G. Severe intestinal involvement in Wegener's granulomatosis. J Gastroenterol Hepatol 2003, 18:749-750.
71. Rasmussen N., Petersen J. Cellular immune responses and pathogenesis in c-ANCA positive vasculitides. J Autoimmun 1993, 6:227-236.
72. Brouwer E., Cohen Tervaert J.W., Weening J.J. Immunohistology of renal biopsies in Wegener's granulomatosis (WG):clues to its pathogenesis. Kidney Int 1991, 39:1055.
73. Mellbye O.J., Mollnes T.E., Steen L.S. IgG subclass distribution and complement activation ability of autoantibodies to neutrophil cytoplasmic antigens (ANCA). Clin Immunol Immunopathol 1994, 70:32-39.
74. Berden A.E., Kallenberg C.G., Savage C.O., et al. Cellular immunity in Wegener's granulomatosis: characterizing T lymphocytes. Arthritis Rheum 2009, 60:1578-1587.
75. Schmitt W., Hagen E., Neumann I., et al. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 2004, 65:1440-1448.
76. Filer A.D., Gardner-Medwin J.M., Thambyrajah J., et al. Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa. Ann Rheum Dis 2003, 62:162-167.
77. Giscombe R., Nityanand S., Lewin N., et al. Expanded T cell populations in patients with Wegener's granulomatosis: characteristics and correlates with disease activity. J Clin Immunol 1998, 18:404-413.
78. Csernok E., Trabandt A., Muller A., et al. Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1999, 42:742-750.
79. Ludviksson B.R. Active Wegener's granulomatosis is associated with HLA-DR+CD4+ T-cells exhibiting an unbalanced Th1-type T-cell cytokine pattern: reversal with IL-10. J Immunol 1998, 160:3602-3609.
80. Popa E.R., Franssen C.F., Limburg P.C., et al. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Arthritis Rheum 2002, 46:1894-1904.
81. Abdulahad W.H., van der Geld Y.M., Stegeman C.A., et al. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney Int 2006, 70:938-947.
82. Abdulahad W.H., Stegeman C.A., Limburg P.C., et al. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2008, 58:2196-2205.
83. Forlow S.B., Schurr J.R., Kolls J.K., et al. Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 2001, 98:3309-3314.
84. Laan M., Cui Z.H., Hoshino H., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999, 162:2347-2352.
85. Van Kooten C., Boonstra J.G., Paape M.E., et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 1998, 9:1526-1534.
86. Jovanovic D.V., Di Battista J.A., Martel-Pelletier J., et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998, 160:3513-3521.
87. Abdulahad W.H., Stegeman C.A., van der Geld Y.M., et al. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2007, 56:2080-2091.
88. Morgan M.D., Day C.J., Piper K.P., et al. Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology 2010, 130(1):64-73.
89. Marinaki S., Neumann I., Kalsch A.I., et al. Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis. Clin Exp Immunol 2005, 140:181-191.
90. Giscombe R., Wang X.B., Kakoulidou M., et al. Characterization of the expanded T-cell populations in patients with Wegener's granulomatosis. J Intern Med 2006, 260:224-230.
91. Popa E.R., Stegeman C.A., Bos N.A., et al. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol 1999, 103:885-894.
92. Voswinkel J., Mueller A., Kraemer J.A., et al. B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006, 65:859-864.
93. Culton D.A., Nicholas M.W., Bunch D.O., et al. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. J Clin Immunol 2007, 27:53-68.
94. Bajema I.M., Hagen E.C., van der Woude F.J., et al. Wegener's granulomatosis: a meta-analysis of 349 literary case reports. J Lab Clin Med 1997, 129:17-22.
95. Mueller A., Holl-Ulrich K., Feller A.C., et al. Immune phenomena in localized and generalized Wegener's granulomatosis. Clin Exp Rheumatol 2003, 21:S49-S54.
96. Eriksson P. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 2005, 257:540-548.
97. Ferraro A.J., Day C.J., Drayson M.T., et al. Effective therapeutic use of rituximab in refractory Wegener's granulomatosis. Nephrol Dial Transplant 2005, 20:622-625.
98. Csernok E., Lamprecht P., Gross W.L. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol 2010, 22:43-48.
99. Stegeman C.A., Cohen Tervaert J.W., de Jong P.E., et al. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996, 335:16-20.
100. Hogan S.L., Cooper G.S., Savitz D.A., et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol 2007, 2:290-299.
101. Pendergraft W.F., Preston G.A., Shah R.R., et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004, 10:72-79.
102. Yang J., Bautz D.J., Lionaki S., et al. ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int 2008, 74:1159-1169.
103. Bautz D.J., Preston G.A., Lionaki S., et al. Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J Am Soc Nephrol 2008, 19:2421-2429.